tiprankstipranks
Trending News
More News >
Photomyne Ltd (IL:PHTM)
:PHTM
Israel Market

Photomyne (PHTM) AI Stock Analysis

Compare
0 Followers

Top Page

IL:PHTM

Photomyne

(PHTM)

Select Model
Select Model
Select Model
Neutral 42 (OpenAI - 5.2)
,
Neutral 42 (OpenAI - 5.2)
,
Neutral 42 (OpenAI - 5.2)
,
Neutral 42 (OpenAI - 5.2)
,
Neutral 42 (OpenAI - 5.2)
,
Neutral 42 (OpenAI - 5.2)
,
Neutral 42 (OpenAI - 5.2)
,
Neutral 42 (OpenAI - 5.2)
Rating:42Neutral
Price Target:
2,154.00
▼(-4.01% Downside)
Action:ReiteratedDate:02/19/26
The score is primarily weighed down by weak financial performance driven by ongoing losses, negative operating/free cash flow, and shrinking equity. Technicals are mixed with a negative longer-term trend, and valuation signals are constrained by negative earnings and no dividend support.
Positive Factors
Revenue rebound
A 25% revenue rebound to 18.4M in 2025 indicates durable demand for Photomyne’s core scanning and preservation apps. Sustained top-line growth supports scale economics for a subscription model, improving unit economics potential as fixed costs spread over larger revenues.
Recurring subscription model
A subscription and in‑app purchase model creates predictable, recurring revenue and customer lifetime value. This structural model supports retention-driven growth, higher revenue visibility, and the ability to monetize feature add-ons over time, aiding long-term margin expansion if acquisition costs are controlled.
Low-to-moderate leverage
Relatively low debt (1.3M) and positive equity give Photomyne balance-sheet breathing room despite losses. Manageable leverage reduces near-term liquidity pressure versus highly levered peers, preserving optionality to invest in product or raise capital under less strained conditions.
Negative Factors
Persistent unprofitability
Multi-year operating and net losses indicate the company still has a structural cost-to-scale mismatch. Continued unprofitability erodes retained earnings, limits reinvestment capacity, and forces reliance on external capital unless margins improve through higher subscription monetization or cost reductions.
Negative cash flow
Consistent negative operating and free cash flow represent ongoing cash burn, increasing the probability of needing external funding. Cash burn constrains product development and marketing investments, raises dilution or debt risks, and reduces resilience to demand or platform shocks.
Eroding equity and assets
A meaningful decline in equity and total assets over two years signals capital erosion from losses. Shrinking balance-sheet cushions reduce strategic flexibility, heighten financing urgency, and can limit ability to pursue partnerships or invest in growth without dilutive or costly capital raises.

Photomyne (PHTM) vs. iShares MSCI Israel ETF (EIS)

Photomyne Business Overview & Revenue Model

Company DescriptionPhotomyne (PHTM) is a technology company specializing in the digitization of physical photographs and memorabilia. The company operates primarily in the consumer and software technology sectors, offering a suite of mobile applications that allow users to scan, store, and share their photo collections seamlessly. Its core products include the Photomyne app, which utilizes advanced scanning technology to quickly capture multiple images, as well as features for organization, editing, and sharing, catering to individuals looking to preserve their memories in a digital format.
How the Company Makes MoneyPhotomyne primarily generates revenue through paid subscriptions and in-app purchases for its consumer mobile applications, where users pay for access to premium features (e.g., higher-volume scanning, advanced enhancement/restoration tools, and other paid functionality) typically offered under recurring subscription plans. Revenue is recognized from these subscription fees and one-time purchases processed through mobile app marketplaces. Information about significant partnerships, enterprise licensing, advertising-based monetization, or material non-consumer revenue streams is null.

Photomyne Financial Statement Overview

Summary
Revenue rebounded in 2025 (+25%), but profitability is weak with a net loss (-4.9M) and operating loss (EBIT -5.4M). Cash flow remains negative (operating CF -2.3M; FCF -2.4M), and equity has declined materially (to 3.7M), increasing execution and funding risk despite low-to-moderate debt.
Income Statement
38
Negative
Revenue rebounded strongly in 2025 to 18.4M (+25.0% growth), but profitability remains the key issue: the company posted a net loss of -4.9M in 2025 following a -4.0M loss in 2024, after a profitable 2023 (net income 2.5M). Gross profit is solid in dollars (12.6M in 2025), yet operating losses (EBIT -5.4M in 2025) suggest the cost structure is still too high versus current scale, making earnings quality and consistency weak despite improved top-line momentum.
Balance Sheet
60
Neutral
Leverage is low-to-moderate overall, with equity still positive in the latest period (2025 stockholders’ equity 3.7M) and debt at 1.3M, but the balance sheet has weakened versus prior years as losses accumulated (equity fell from 8.5M in 2024 and 12.9M in 2023). Total assets declined to 12.6M in 2025 from 14.4M in 2024, signaling reduced balance-sheet flexibility. The main strength is that debt does not appear excessive; the main risk is continued losses pressuring equity further.
Cash Flow
32
Negative
Cash generation is a concern: operating cash flow was negative across most years and worsened again in 2025 to -2.3M (from -3.4M in 2024, after a positive 0.8M in 2023). Free cash flow was also negative in 2025 (-2.4M) and deteriorated sharply versus the prior period (free cash flow growth -44.7% in 2025). This profile implies ongoing cash burn and a higher likelihood of needing external funding unless profitability and working-capital dynamics improve.
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue14.73M18.41M13.04M13.33M16.16M12.32M
Gross Profit10.08M12.56M8.99M9.43M11.38M8.34M
EBITDA-5.56M-5.18M-4.74M2.06M-68.00K-6.28M
Net Income-4.99M-4.93M-3.97M2.50M-1.07M-6.35M
Balance Sheet
Total Assets13.43M12.58M14.43M17.83M17.16M18.52M
Cash, Cash Equivalents and Short-Term Investments10.25M9.52M12.49M15.76M14.52M15.85M
Total Debt750.00K1.31M20.00K165.00K252.00K220.98K
Total Liabilities7.97M8.89M5.92M4.95M6.89M7.59M
Stockholders Equity5.46M3.69M8.51M12.88M10.27M10.93M
Cash Flow
Free Cash Flow-4.29M-2.38M-3.44M804.00K-101.00K-4.03M
Operating Cash Flow-4.22M-2.31M-3.41M814.00K-59.00K-3.99M
Investing Cash Flow4.15M3.81M2.60M-11.38M11.00M-11.51M
Financing Cash Flow-1.09M-696.03K-653.00K-110.00K-110.00K17.06M

Photomyne Technical Analysis

Technical Analysis Sentiment
Negative
Last Price2244.00
Price Trends
50DMA
2031.46
Positive
100DMA
2090.11
Positive
200DMA
2322.20
Negative
Market Momentum
MACD
46.60
Positive
RSI
45.34
Neutral
STOCH
95.65
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IL:PHTM, the sentiment is Negative. The current price of 2244 is above the 20-day moving average (MA) of 2171.25, above the 50-day MA of 2031.46, and below the 200-day MA of 2322.20, indicating a neutral trend. The MACD of 46.60 indicates Positive momentum. The RSI at 45.34 is Neutral, neither overbought nor oversold. The STOCH value of 95.65 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IL:PHTM.

Photomyne Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
61
Neutral
$37.18B12.37-10.20%1.83%8.50%-7.62%
53
Neutral
₪162.55M-2.471290.36%-214.81%
42
Neutral
₪56.50M-3.4114.39%-1797.14%
40
Underperform
₪35.28M-2.78-23.68%31.97%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IL:PHTM
Photomyne
2,100.00
-999.00
-32.24%
IL:TECT
Tectona
225.00
-88.00
-28.12%
IL:NRGN
Nrgene
265.10
-24.90
-8.59%
IL:TRAN
Trucknet
54.00
-36.70
-40.46%
IL:PRPD
PROPDO LTD
2,315.00
332.00
16.74%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Feb 19, 2026